IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease

Circulation Journal

Volumn 74, Issue 5, 2010, Pages 983-989

  Weng, Ken Pen ^a,b,c   Hsieh, Kai Sheng ^a   Hwang, Yu Tung ^a   Huang, Shih Hui ^c   Lai, Tsung Jen ^d   Yuh, Yeong Seng ^e   Hou, Yu Yi ^f   Lin, Chu Chuan ^a   Huang, Shih Chen ^g   Chang, Chian Kai ^h   Lin, Ming Wei ^a   Ger, Luo Ping ^d,g  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f Department of Otolaryngolog ^*  (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Coronary artery lesions; Interleukin 10 polymorphism; Kawasaki disease

Indexed keywords

ADENINE; CYTOSINE; GUANINE; IMMUNOGLOBULIN; INTERLEUKIN 10; THYMINE;

ACUTE DISEASE; ADULT; ALLELE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK REDUCTION;

ACUTE DISEASE; ALLELES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HAPLOTYPES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; INTERLEUKIN-10; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77951739765     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0801     Document Type: Article

References (34)

1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771.
2. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. Coronary arterial lesions of Kawasaki disease: Cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986; 7: 3-9.
3. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Treatment of acute Kawasaki disease: Aspirin's role in the febrile stage revisited. Pediatrics 2004; 114: e689-e693.
4. Takatsuki S, Ito Y, Takeuchi D, Hoshida H, Nakayama T, Matsuura H, et al. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J 2009; 73: 1315-1318.
5. Weng KP, Hsieh KS, Ho TY, Huang SH, Lai CR, Chiu YT, et al. IL-1B polymorphism in association with initial IVIG treatment failure in Taiwanese children with Kawasaki disease. Circ J 2010; 74: 544-551.
6. Hui-Yuen J, Duong TT, Yeung RSM. TNF-a is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 2006; 176: 6294-6301.
7. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997; 112: 152-156.
8. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121: 924-926.
9. Kim DS, Lee HK, Noh GW, Lee SI, Lee KY. Increased serum interleukin-10 level in Kawasaki disease. Yonsei Med J 1996; 37: 125-130.
10. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, et al. A polymorphism in the promoter of the CD14 gene (CD14/ -159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 2003; 143: 357-362.
11. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004; 56: 953-959.
12. Park JA, Shin KS, Kim YW. Polymorphism of matrix metalloproteinase 3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 2005; 20: 607-611.
13. Biezeveld MH, Geissler J, Weverling GJ, Kuipers IM, Lam J, Ottenkamp J, et al. Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum 2006; 54: 369-376.
14. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Erke Zazhi 2003; 41: 598-602 (in Chinese).
15. Jin HS, Kim HB, Kim BS, Lee JK, Seo EJ, Yoo HW, et al. The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 2007; 61: 584-587.
16. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
17. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999; 1: 151-155.
18. Yamazaki K, Tabeta K, Nakajima T, Ohsawa Y, Ueki K, Itoh H, et al. Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early-onset periodontitis. J Clin Periodontol 2001; 28: 828-832.
19. Reichert S, Machulla HK, Klapproth J, Zimmermann U, Reichert Y, Gläser CH, et al. The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis. J Periodont Res 2008; 43: 40-47.
20. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090-1095.
21. Crawley E, Woo P, Isenberg DA. Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2017-2018.
22. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, et al. Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease. J Korean Med Sci 2009; 24: 438-442.
23. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Ministry of Health and Welfare; 1984.
24. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 133-139.
25. Noh GW, Lee WG, Lee W, Lee K. Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease. Immunol Lett 1998; 62: 19-24.
26. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al; CAPTURE Study Investigators. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107: 2109-2114.
27. Claudino M, Trombone AP, Cardoso CR, Ferreira SB Jr, Martins W Jr, Assis GF, et al. The broad effects of the functional IL-10 promoter-592 polymorphism: Modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008; 84: 1565-1573.
28. Fu JR, Li CR, Zhou YF, Zhou YD. Effect of interleukin-10 on the endothelial damage mediated by inflammatory cytokines in Kawasaki disease. Chin J Rheumatol 2001; 5: 363-366 (in Chinese).
29. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005; 146: 662-667.
30. Oishi T, Fujieda M, Shiraishi T, Ono M, Inoue K, Takahashi A, et al. Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm: A 1-month-old girl. Circ J 2008; 72: 850-852.
31. Huang SM, Weng KP, Chang JS, Lee WY, Huang SH, Hsieh KS. Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: A pilot study. Circ J 2008; 72: 1583-1587.
32. Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, Matsumura M, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J 2009; 73: 1319-1323.
33. Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C. Remodeling of coronary artery lesions due to Kawasaki disease: Comparison of arteriographic and immunohistochemical findings. Jpn Heart J 2000; 41: 245-256.
34. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. Circulation 2000; 101: 2935-2941.